| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX002 (ip) | median survival time | saline | 90.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX002 (ip) | median survival time | saline | 135.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 60; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 107.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | median survival time | saline | 90.0 mg/kg/injection | 107.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q04DX002 (ip) | median survival time | saline | 135.0 mg/kg/injection | 0.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |